AstraZeneca revises vaccine efficacy to 76 per cent
AstraZeneca said its COVID-19 vaccine is 76 percent effective for preventing symptomatic illness after a new analysis of updated U.S. ...
Tag: clinical trial
Bharat Biotech announces phase 3 results of COVAXIN
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of ...
Latest News
